The expression and clinical significance of vascular endothelial growth factor 121 (VEGF_(121) ) in gastric carcinoma
Zhou Ming
Abstract
Zhou Ming
Abstract
Objective To investigate the expression of angiogenic factors VEGF 121 in gastric carcinoma ,tumour microvessel density (MVD) immunoreactivity of gastric carcinoma and whether clinicopatholgical features of gastric carcinoma are related to the expression of VEGF 121 .Methods Immunohistochemistry technique (SP or SABC) was used to test the expression of the angiogenic factor VEGF 121 and CD34 in 59 gastric carcinoma specimens,15 normal gastric membrane beside carcinoma specimens and 25 gastric benign lesions specimens embedded in paraffin wax.Results (1) Immunoreactivity of VEGF 121 was found in cytoplastic and cell surface of most gastric carcinoma cell (positive staining 47 in 59), the rate of positive staining in gastric carcinoma was the highest (P0.05); the MVD of gastric carcinoma was higher than that of normal gastric tissue beside carcinoma and that of gastric benign lesions (P0.05), Moreover, the shape and structure of microvessel was abnormal. (2)The expression of VEGF 121 vavies with different infiltration depth and with or without distant metastasis(P0.05).Conclusion Infiltrating depth and distantant metastasis are positively related to the expression of VEGF 121 . VEGF 121 expression may be useful to evaluate clinical progression of gastric carcinoma.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To investigate the expression of angiogenic factors VEGF 121 in gastric carcinoma ,tumour microvessel density (MVD) immunoreactivity of gastric carcinoma and whether clinicopatholgical features of gastric carcinoma are related to the expression of VEGF 121 .Methods Immunohistochemistry technique (SP or SABC) was used to test the expression of the angiogenic factor VEGF 121 and CD34 in 59 gastric carcinoma specimens,15 normal gastric membrane beside carcinoma specimens and 25 gastric benign lesions specimens embedded in paraffin wax.Results (1) Immunoreactivity of VEGF 121 was found in cytoplastic and cell surface of most gastric carcinoma cell (positive staining 47 in 59), the rate of positive staining in gastric carcinoma was the highest (P0.05); the MVD of gastric carcinoma was higher than that of normal gastric tissue beside carcinoma and that of gastric benign lesions (P0.05), Moreover, the shape and structure of microvessel was abnormal. (2)The expression of VEGF 121 vavies with different infiltration depth and with or without distant metastasis(P0.05).Conclusion Infiltrating depth and distantant metastasis are positively related to the expression of VEGF 121 . VEGF 121 expression may be useful to evaluate clinical progression of gastric carcinoma.
Key concepts: Immunohistochemistry, Pathology, Gastric carcinoma, CD34, Carcinoma, Vascular endothelial growth factor, Medicine, Metastasis